Annual report [Section 13 and 15(d), not S-K Item 405]

SCHEDULE OF REVENUE RECOGNITION (Details)

v3.25.1
SCHEDULE OF REVENUE RECOGNITION (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Product Information [Line Items]    
Total net revenue $ 9,362,022 $ 2,532,499
Health Care, Patient Service [Member]    
Product Information [Line Items]    
Total net revenue [1] 8,175,670 2,199,558
Histology Service Fees [Member]    
Product Information [Line Items]    
Total net revenue 1,103,751 272,660
Medical Director Fees [Member]    
Product Information [Line Items]    
Total net revenue 66,576 19,324
Department of Defense Observational Studies [Member]    
Product Information [Line Items]    
Total net revenue 8,654 19,442
Other Revenues [Member]    
Product Information [Line Items]    
Total net revenue $ 7,371 $ 21,515
[1] Patient services fees include direct billing for CyPath® Lung diagnostic test of approximately $516,000 and $35,000 for the years ended December 31, 2024 and 2023.